These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16495919)

  • 1. Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration.
    Lee CM; Tannock IF
    Br J Cancer; 2006 Mar; 94(6):863-9. PubMed ID: 16495919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.
    Yu M; Lee C; Wang M; Tannock IF
    Cancer Sci; 2015 Oct; 106(10):1438-47. PubMed ID: 26212113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
    Patel KJ; Trédan O; Tannock IF
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):127-38. PubMed ID: 23680920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors.
    Tunggal JK; Cowan DS; Shaikh H; Tannock IF
    Clin Cancer Res; 1999 Jun; 5(6):1583-6. PubMed ID: 10389947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosome Inhibitors Enhance the Chemotherapeutic Activity of Doxorubicin in HepG2 Cells.
    Li Y; Sun Y; Jing L; Wang J; Yan Y; Feng Y; Zhang Y; Liu Z; Ma L; Diao A
    Chemotherapy; 2017; 62(2):85-93. PubMed ID: 27764836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers.
    Tunggal JK; Melo T; Ballinger JR; Tannock IF
    Int J Cancer; 2000 Apr; 86(1):101-7. PubMed ID: 10728602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture.
    Kyle AH; Huxham LA; Chiam AS; Sim DH; Minchinton AI
    Cancer Res; 2004 Sep; 64(17):6304-9. PubMed ID: 15342419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents.
    Raghunand N; Mahoney BP; Gillies RJ
    Biochem Pharmacol; 2003 Oct; 66(7):1219-29. PubMed ID: 14505801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine.
    Sorensen M; Sehested M; Jensen PB
    Biochem Pharmacol; 1997 Aug; 54(3):373-80. PubMed ID: 9278096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.
    Kuznik A; Bencina M; Svajger U; Jeras M; Rozman B; Jerala R
    J Immunol; 2011 Apr; 186(8):4794-804. PubMed ID: 21398612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes.
    van Weert AW; Geuze HJ; Groothuis B; Stoorvogel W
    Eur J Cell Biol; 2000 Jun; 79(6):394-9. PubMed ID: 10928454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-responsive cationic liposome for endosomal escape mediated drug delivery.
    Rayamajhi S; Marchitto J; Nguyen TDT; Marasini R; Celia C; Aryal S
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110804. PubMed ID: 31972443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase.
    Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Yang H
    J Pharm Pharmacol; 2008 Dec; 60(12):1651-7. PubMed ID: 19000370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical model of doxorubicin penetration through multicellular layers.
    Evans CJ; Phillips RM; Jones PF; Loadman PM; Sleeman BD; Twelves CJ; Smye SW
    J Theor Biol; 2009 Apr; 257(4):598-608. PubMed ID: 19183560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients.
    Salvatorelli E; Menna P; Paz OG; Chello M; Covino E; Singer JW; Minotti G
    J Pharmacol Exp Ther; 2013 Feb; 344(2):467-78. PubMed ID: 23192654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx.
    Veldman RJ; Zerp S; van Blitterswijk WJ; Verheij M
    Br J Cancer; 2004 Feb; 90(4):917-25. PubMed ID: 14970874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and chloroquine coencapsulated liposomes: preparation and improved cytotoxicity on human breast cancer cells.
    Qiu L; Yao M; Gao M; Zhao Q
    J Liposome Res; 2012 Sep; 22(3):245-53. PubMed ID: 22607110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells.
    Zayed GM; Kamal I; Abdelhafez WA; M Alsharif F; Amin MA; Shaykoon MSA; Sarhan HA; Abdelsalam AM
    Pharm Res; 2018 Mar; 35(6):112. PubMed ID: 29603025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.